What does CUSIP 462260100 represent in this 13F holders report?

CUSIP 462260100 is the security identifier for IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock in Q1 2026?

113 institutional investors reported IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock for Q1 2026. Use the holders table for investor-level position and value details.

IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA)

CUSIP: 462260100

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Common Stock
Shares outstanding: 395,322,451
Total 13F shares: 50,723,573
Share change: +5,061,674
Total reported value: $177,954,845
Price per share: $3.51
Number of holders: 113
Value change: +$17,861,511
Number of buys: 60
Number of sells: 37

Quarterly Holders Quick Answers

What is CUSIP 462260100?
CUSIP 462260100 identifies IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 462260100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Wayne P. Rothbaum	3/4/5	Director	— mixed-class rows	28,167,333 mixed-class rows	$257,731,097	—	01 Mar 2024	3/4/5
BlackRock, Inc.	13F 13D/G	Company	6.4% from 13D/G	29,518,125	$80,584,481	—	31 Dec 2025	13F 13D/G
MHR FUND MANAGEMENT LLC	13F	Company	7.3%	28,967,103	$79,080,191	—	31 Dec 2025	13F
VANGUARD GROUP INC	13F	Company	6.9%	27,207,079	$74,275,326	—	31 Dec 2025	13F
STATE STREET CORP	13D/G 13F	STATE STREET CORPORATION · Company	5.1%	20,161,445	$55,847,203	$0	31 Dec 2025	13D/G 13F
PERCEPTIVE ADVISORS LLC	13D/G 13F	Company	3.8%	12,808,788	$45,599,285	-$33,120,382	31 Mar 2025	13D/G 13F
BANK OF AMERICA CORP /DE/	13F	Company	3.6%	14,277,813	$38,978,430	—	31 Dec 2025	13F
Invenomic Capital Management LP	13F	Company	3%	11,959,505	$32,649,449	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	2.3%	9,191,840	$25,093,723	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	2.2%	8,607,564	$23,498,650	—	31 Dec 2025	13F
Long Focus Capital Management, LLC	13F	Company	2.2%	8,600,000	$23,478,000	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2%	7,991,640	$21,820,558	—	31 Dec 2025	13F
Palo Alto Investors LP	13F	Company	1.8%	7,116,676	$19,428,525	—	31 Dec 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.7%	6,585,532	$17,978,502	—	31 Dec 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	1.3%	4,948,614	$13,509,716	—	31 Dec 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	1.1%	4,397,989	$12,006,510	—	31 Dec 2025	13F
HRT FINANCIAL LP	13F	Company	1.1%	4,356,010	$11,891,000	—	31 Dec 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	0.97%	3,829,795	$10,455,340	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.91%	3,583,810	$9,783,801	—	31 Dec 2025	13F
CITADEL ADVISORS LLC	13F	Company	0.8%	3,143,091	$8,580,638	—	31 Dec 2025	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.76%	3,015,000	$8,230,950	—	31 Dec 2025	13F
JPMORGAN CHASE & CO	13F	Company	0.76%	3,001,502	$8,194,101	—	31 Dec 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.7%	2,753,343	$7,516,626	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.65%	2,579,594	$7,042,291	—	31 Dec 2025	13F
Merrill A. Mcpeak	3/4/5	Director	— mixed-class rows	618,783 mixed-class rows	$5,661,865	—	01 Mar 2024	3/4/5
WELLS FARGO & COMPANY/MN	13F	Company	0.5%	1,993,337	$5,441,810	—	31 Dec 2025	13F
Orion Investment Co	13F	Company	0.47%	1,856,934	$5,069,430	—	31 Dec 2025	13F
Rhenman & Partners Asset Management AB	13F	Company	0.4%	1,595,327	$4,355,243	—	31 Dec 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.39%	1,539,110	$4,202,544	—	31 Dec 2025	13F
B Group, Inc.	13F	Company	0.38%	1,500,000	$4,095,000	—	31 Dec 2025	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.36%	1,425,088	$3,890,490	—	31 Dec 2025	13F
Nuveen, LLC	13F	Company	0.35%	1,385,988	$3,783,748	—	31 Dec 2025	13F
C WorldWide Group Holding A/S	13F	Company	0.32%	1,260,000	$3,440,000	—	31 Dec 2025	13F
Invesco Ltd.	13F	Company	0.32%	1,251,665	$3,417,046	—	31 Dec 2025	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.3%	1,191,828	$3,255,000	—	31 Dec 2025	13F
BARCLAYS PLC	13F	Company	0.29%	1,127,157	$3,077,139	—	31 Dec 2025	13F
Mirador Capital Partners LP	13F	Company	0.26%	1,034,544	$2,824,305	—	31 Dec 2025	13F
Bank of New York Mellon Corp	13F	Company	0.24%	955,467	$2,608,425	—	31 Dec 2025	13F
Susquehanna Portfolio Strategies, LLC	13F	Company	0.23%	914,449	$2,496,446	—	31 Dec 2025	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.22%	872,985	$2,383,000	—	31 Dec 2025	13F
Walleye Capital LLC	13F	Company	0.21%	822,754	$2,246,118	—	31 Dec 2025	13F
Frederick G. Vogt	3/4/5	Interim CEO & General Counsel, Director	— mixed-class rows	764,538 mixed-class rows	$2,134,298	+$42,250	09 Mar 2026	3/4/5
UBS Group AG	13F	Company	0.19%	764,154	$2,086,141	—	31 Dec 2025	13F
Aberdeen Group plc	13F	Company	0.19%	759,522	$2,073,495	—	31 Dec 2025	13F
Rafferty Asset Management, LLC	13F	Company	0.18%	706,450	$1,928,609	—	31 Dec 2025	13F
DEUTSCHE BANK AG\	13F	Company	0.17%	690,416	$1,884,836	—	31 Dec 2025	13F
QVT Financial LP	13F	Company	0.17%	678,564	$1,852,480	—	31 Dec 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.16%	651,000	$1,777,230	—	31 Dec 2025	13F
Voleon Capital Management LP	13F	Company	0.16%	630,257	$1,720,602	—	31 Dec 2025	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.16%	628,537	$1,715,906	—	31 Dec 2025	13F

Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q1 2026

As of 31 Mar 2026, IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by 113 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,723,573 shares. The largest 10 holders included VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD PORTFOLIO MANAGEMENT LLC, Nuveen, LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD FIDUCIARY TRUST CO, UBS Group AG, C WorldWide Group Holding A/S, Mirador Capital Partners LP, Bank of New York Mellon Corp, and SECTOR GAMMA AS. This page lists 113 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

259

Q1 2026 holders

113

Holder diff

-146

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.